PERCEPTIVE ADVISORS LLC 13D and 13G filings for Leap Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 2:30 pm Sale |
2022-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 672,650 6.800% |
-175,000![]() (-20.65%) |
Filing |
2022-02-14 6:55 pm Unchanged |
2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 847,650 9.600% |
0 (Unchanged) |
Filing |
2021-02-16 3:42 pm Purchase |
2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 847,650 14.200% |
175,000![]() (+26.02%) |
Filing |